Eisai, Biogen Alzheimer's Drug Leqembi Would Cost US Medicare...
Eisai, Biogen Alzheimer's Drug Leqembi Would Cost US Medicare up to $5 Billion a Year, Study Finds More Reuters FILE PHOTO: The Alzheimer's drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout...